Marco Colleoni Selected Research

Marco Colleoni Research Topics

Disease

181	Breast Neoplasms (Breast Cancer) 04/2024 - 09/2002
83	Neoplasms (Cancer) 04/2024 - 12/2003
16	Triple Negative Breast Neoplasms 12/2023 - 09/2008
8	Neutropenia 01/2021 - 04/2016
6	Disease Progression 01/2023 - 03/2004
5	Neoplasm Metastasis (Metastasis) 11/2021 - 09/2002
4	Pathologic Complete Response 04/2024 - 08/2014
4	Infections 01/2021 - 01/2018
4	Hypertension (High Blood Pressure) 01/2018 - 12/2007
4	Ductal Carcinoma 09/2015 - 07/2009
3	Alopecia (Baldness) 01/2023 - 01/2019
3	Febrile Neutropenia 01/2021 - 10/2016
3	Heart Failure 01/2020 - 02/2007
3	Arthralgia (Joint Pain) 01/2018 - 02/2007
3	Inflammatory Breast Neoplasms 01/2018 - 09/2008
3	Hypercholesterolemia 04/2017 - 02/2007
3	Lobular Carcinoma 09/2015 - 10/2009
2	Residual Neoplasm 10/2021 - 03/2011
2	Fatigue 12/2020 - 01/2020
2	Nausea 12/2020 - 07/2018
2	Cardiotoxicity 01/2020 - 12/2010
2	Wounds and Injuries (Trauma) 01/2019 - 01/2018
2	Hot Flashes 11/2016 - 02/2007
2	Lymphatic Metastasis 08/2014 - 10/2010
2	Bone Fractures (Bone Fracture) 04/2008 - 02/2007
2	Venous Thromboembolism 10/2007 - 10/2005
1	Leiomyosarcoma 01/2023

Drug/Important Bio-Agent (IBA)

73	Hormones (Hormone)IBA 05/2023 - 10/2004
36	Tamoxifen FDA LinkGeneric 06/2023 - 03/2006
28	Estrogen ReceptorsIBA 01/2023 - 10/2004
27	Letrozole (Femara)FDA LinkGeneric 01/2023 - 02/2007
20	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 06/2004
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 03/2004
18	ErbB Receptors (EGF Receptor)IBA 01/2023 - 09/2008
18	Phenobarbital (Luminal)FDA Link 12/2021 - 04/2012
16	Trastuzumab (Herceptin)FDA Link 04/2024 - 09/2006
15	Aromatase InhibitorsIBA 06/2023 - 12/2007
15	palbociclibIBA 01/2022 - 04/2016
14	human ERBB2 proteinIBA 04/2024 - 06/2010
13	exemestane (Aromasin)FDA Link 01/2023 - 07/2014
11	Estrogens (Estrogen)FDA Link 01/2023 - 06/2004
11	Fluorouracil (Carac)FDA LinkGeneric 08/2015 - 09/2005
10	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 09/2002
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2009
10	Fulvestrant (Faslodex)FDA Link 01/2022 - 09/2012
9	Capecitabine (Xeloda)FDA Link 01/2023 - 10/2008
9	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 11/2006
7	pertuzumabIBA 04/2024 - 01/2018
7	SteroidsIBA 08/2013 - 10/2004
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 09/2008
6	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023 - 12/2008
6	AnthracyclinesIBA 12/2021 - 05/2008
6	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2008
6	Epirubicin (Ellence)FDA LinkGeneric 08/2015 - 11/2006
5	ribociclibIBA 01/2023 - 01/2018
5	liposomal doxorubicin (Doxil)FDA Link 12/2021 - 12/2010
5	Progesterone FDA LinkGeneric 01/2018 - 09/2008
4	ParaffinIBA 12/2023 - 07/2012
4	Formaldehyde (Formol)FDA Link 12/2023 - 07/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2010
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2019 - 12/2003
3	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 01/2018
3	Cyclin-Dependent Kinase 4IBA 01/2022 - 11/2018
3	taxaneIBA 10/2021 - 01/2008
3	Triptorelin Pamoate (Trelstar)FDA Link 10/2019 - 04/2010
3	Alkylating AgentsIBA 08/2014 - 06/2010
3	1-dodecylpyridoxal (PLD)IBA 04/2013 - 12/2010
2	Docetaxel (Taxotere)FDA Link 04/2024 - 10/2022
2	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2021
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 01/2018
2	Thymidine KinaseIBA 01/2023 - 01/2022
2	Gemcitabine FDA Link 10/2021 - 09/2008
2	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 01/2019
2	Biosimilar PharmaceuticalsIBA 01/2020 - 12/2019
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 03/2016
2	MethyltransferasesIBA 08/2014 - 07/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2012 - 06/2012
2	Hemoglobins (Hemoglobin)IBA 06/2012 - 01/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010 - 01/2009
2	Leucovorin (Folinic Acid)FDA Link 12/2008 - 09/2002
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2004 - 09/2002
1	Granzymes (Granzyme)IBA 09/2023
1	Immune Checkpoint InhibitorsIBA 09/2023
1	avelumabIBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	talazoparibIBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2023
1	sperm releasing substanceIBA 01/2022

Therapy/Procedure

95	Therapeutics 04/2024 - 01/2003
72	Drug Therapy (Chemotherapy) 04/2024 - 09/2002
17	Adjuvant Chemotherapy 12/2021 - 04/2003
15	Neoadjuvant Therapy 11/2022 - 02/2008
6	Radiotherapy 12/2020 - 10/2010
6	Mastectomy (Mammectomy) 01/2018 - 10/2010
3	Catheters 10/2007 - 10/2005
2	Drug Tapering 12/2020 - 10/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 10/2011
2	Segmental Mastectomy (Lumpectomy) 10/2016 - 11/2012
1	Immunotherapy 09/2023
1	Time-to-Treatment 01/2023